Please login to the form below

Not currently logged in
Email:
Password:

Fresenius Kabi

This page shows the latest Fresenius Kabi news and features for those working in and with pharma, biotech and healthcare.

Fresenius says Akorn investigation could affect takeover

Fresenius says Akorn investigation could affect takeover

Fresenius Kabi says its $4.3bn deal to acquire US generic drugmaker Akorn Pharma could be scuppered by an FDA probe of the generic drug manufacturer. ... Akorn put out its own statement about the FDA investigation saying: “Akorn and Fresenius Kabi,

Latest news

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    It is encouraging, therefore, to see Fresenius’s share price increase by 2% following the announcement that its subsidiary Fresenius Kabi is making two acquisitions worth over $5.5bn. ... Fresenius will pay Merck a single digit royalty on sales.

  • Pharma deals during March 2013 Pharma deals during March 2013

    39.5. Goa Formulations/ Fresenius Kabi India. Acquisition. Manufacturer of drugs including intravenous fluids.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    Hikma appoints group scientific officer and global head of R&D. Dr Surendera Tyagi joins the pharma group from Fresenius Kabi. ... He joins the pharma group from Fresenius Kabi, where he most recently led its US innovation and development centre.

  • Bartenbach adds to healthcare management team Bartenbach adds to healthcare management team

    Bartenbach adds to healthcare management team. Anja Treiber has worked with CSL Behring, Novo Nordisk, Fresenius Kabi and Merz Pharma. ... In the last two years, Treiber has focused on international pharma clients including CSL Behring, Novo Nordisk,

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories. “

  • Biotest makes two senior management appointments Biotest makes two senior management appointments

    Biotest makes two senior management appointments. Promotion for Jörg Schüttrumpf while Markus Rothenburger joins from Fresenius Kabi. ... Prof Rothenburger joins Biotest from his role as VP medical and clinical affairs at Fresenius Kabi.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics